Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Characterizing the role of continuous hemofiltration in the reconstitution and functional preservation of donor hearts during ex-situ heart perfusion

EF 2022-23

Résumé
Heart transplantation is regarded as the gold standard treatment for heart failure, an illness that 750,000 Canadians will suffer from this year. The supply of donor hearts is severely limited by conventional static cold storage, which limits safe viability time ex-situ to 4-6 hours and precludes meaningful evaluation of cardiac function pre-transplant. Ex-situ heart perfusion answers these limitations by instead keeping the heart functioning while supplying it with an oxygenated and nutrient rich perfusate. Though clinical ESHP has extended the maximum safe preservation time, hearts nonetheless suffer a steady functional decline during prolonged perfusion. This observation is hypothesized to be the result of accumulated toxic metabolic products, as well as the release of pro-inflammatory and oxidative stress-inducing substrates to the perfusate, mediating steady functional decline over the course of perfusion. Continuous hemofiltration (CH) can be employed to not only remove circulating metabolic, oxidative, and inflammatory stressors, but also enable a gradual introduction of beneficial substrates that would otherwise be depleted throughout perfusion. While studies have already demonstrated the functional and preservative benefits of CH during ESHP, they have not yet identified the specific mechanisms of action to account for these benefits. Our project will conduct a biochemical analysis of hearts subject to ESHP with CH to identify the corresponding mechanisms. Optimized targeting of such mechanisms would enable further improved functional preservation through ESHP, allowing better post-transplant outcomes, improved donor-recipient matching, and a widened donation locale for heart transplantation.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486055
Name
Wagner Mitchell J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterizing the role of continuous hemofiltration in the reconstitution and functional preservation of donor hearts during ex-situ heart perfusion
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cross Circulation; Cytokine Adsorption; Ex-Situ Heart Perfusion; Heart Failure; Heart Transplanation; Hemodialysis; Hemofiltration; Organ Preservation; Organ Reconditioning
Abstract
Heart transplantation is regarded as the gold standard treatment for heart failure, an illness that 750,000 Canadians will suffer from this year. The supply of donor hearts is severely limited by conventional static cold storage, which limits safe viability time ex-situ to 4-6 hours and precludes meaningful evaluation of cardiac function pre-transplant. Ex-situ heart perfusion answers these limitations by instead keeping the heart functioning while supplying it with an oxygenated and nutrient rich perfusate. Though clinical ESHP has extended the maximum safe preservation time, hearts nonetheless suffer a steady functional decline during prolonged perfusion. This observation is hypothesized to be the result of accumulated toxic metabolic products, as well as the release of pro-inflammatory and oxidative stress-inducing substrates to the perfusate, mediating steady functional decline over the course of perfusion. Continuous hemofiltration (CH) can be employed to not only remove circulating metabolic, oxidative, and inflammatory stressors, but also enable a gradual introduction of beneficial substrates that would otherwise be depleted throughout perfusion. While studies have already demonstrated the functional and preservative benefits of CH during ESHP, they have not yet identified the specific mechanisms of action to account for these benefits. Our project will conduct a biochemical analysis of hearts subject to ESHP with CH to identify the corresponding mechanisms. Optimized targeting of such mechanisms would enable further improved functional preservation through ESHP, allowing better post-transplant outcomes, improved donor-recipient matching, and a widened donation locale for heart transplantation.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wagner, Mitchell J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~